Prostate cancer screening slashes risk of dying from the disease by 13 per cent, major study reveals
Screening men for prostate cancer would save thousands of lives by slashing their risk of dying from the disease by 13 per cent, a major study reveals. Testing led to a ‘sustained reduction’ in deaths ...
A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of ...
Hosted on MSN
High-tech laser prostate reduction operations now being delivered in Northants as a day case
Patients say the difference it makes is amazing. A state-of-the-art laser prostate reduction operation is now being successfully delivered in the county as a day case procedure. HOLEP, or Holmium ...
MIAMI - Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) announced Tuesday that its lead drug candidate, Telomir-1, reduced prostate-specific antigen (PSA) levels in androgen-responsive human prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results